Valuation : Dermapharm Holding SE

Market Cap 1.96B 2.28B 1.85B 1.69B 3.15B 215B 3.16B 21.81B 8.46B 110B 8.56B 8.37B 356B P/E 2026 *
15.1x
P/E 2027 * 13.3x
Enterprise Value 2.77B 3.22B 2.61B 2.38B 4.46B 304B 4.47B 30.84B 11.97B 156B 12.1B 11.84B 503B EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.11x
Free-Float
10.7%
Yield 2026 *
2.58%
Yield 2027 * 2.88%
1 day-0.38%
1 week+0.13%
Current month+1.54%
1 month-3.06%
3 months-16.72%
6 months+3.12%
Current year+0.64%
1 week 38.3
Extreme 38.3
40.15
1 month 38.3
Extreme 38.3
42.15
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
5/14/26 A Buy

Chairman

380,000 0.7670%
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 150 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.67%+0.13%+20.00%-11.57% 2.28B
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
+0.14%-0.47%+30.20%+41.44% 352B
-1.33%+4.72%+24.62%+48.58% 304B
-1.15%+0.30%-0.69%+13.20% 252B
-1.55%+1.11%+54.15%+75.59% 236B
-0.88%+1.15%-14.60%-54.96% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.88%+1.15%+27.79%+47.12% 368.06B
Weighted average by Cap. -0.96%+0.62%+37.62%+67.96%

Financials

2026 *2027 *
Net sales 1.21B 1.4B 1.14B 1.04B 1.94B 133B 1.95B 13.44B 5.21B 68.04B 5.27B 5.16B 219B 1.25B 1.46B 1.18B 1.08B 2.02B 138B 2.02B 13.95B 5.41B 70.62B 5.47B 5.35B 228B
Net income 137M 160M 129M 118M 221M 15.06B 221M 1.53B 592M 7.73B 599M 586M 24.89B 155M 181M 146M 134M 250M 17.04B 250M 1.73B 670M 8.74B 678M 663M 28.17B
Net Debt 812M 943M 764M 698M 1.31B 89.07B 1.31B 9.02B 3.5B 45.7B 3.54B 3.47B 147B 687M 798M 646M 590M 1.1B 75.37B 1.11B 7.64B 2.96B 38.67B 3B 2.93B 125B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,619
Date Price Change Volume
04/09/26 €39.60 +1.67% 28,800
03/09/26 €38.95 +1.70% 40,395
02/09/26 €38.30 -1.79% 38,152
01/09/26 €39.00 0.00% 11,839
31/08/26 €39.00 -1.39% 476,211
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
39.60EUR
Average target price
51.00EUR
Spread / Average Target
+28.79%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!